77-67-8
77-67-8
Chemical Structure
Ethosuximide
- CAS No.: 77-67-8
- Formula:C7H11NO2
- Molecular Weight:141.17
IUPAC Name: 3-ethyl-3-methylpyrrolidine-2,5-dione
InChIKey: HAPOVYFOVVWLRS-UHFFFAOYSA-N
SMILES: O=C(C(C)(CC)C1)NC1=O
Biological Activity: Ethosuximide, a widely prescribed anti-epileptic agent, improves the phenotypes of multiple neurodegenerative disease models and blocks the low voltage activated T-type calcium channel.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Ethosuximide | 99.35% | Ethosuximide, a widely prescribed anti-epileptic agent, improves the phenotypes of multiple neurodegenerative disease models and blocks the low voltage activated T-type calcium channel. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ethosuximide (Standard) | ≥98% | Ethosuximide (Standard) is the analytical standard of Ethosuximide. This product is intended for research and analytical applications. Ethosuximide, a widely prescribed anti-epileptic agent, improves the phenotypes of multiple neurodegenerative disease models and blocks the low voltage activated T-type calcium channel. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ethosuximide-d3 | Ethosuximide-d3 is the deuterium labeled Ethosuximide. Ethosuximide, a widely prescribed anti-epileptic agent, improves the phenotypes of multiple neurodegenerative disease models and blocks the low voltage activated T-type calcium channel. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ethosuximide-13C, d3 | Ethosuximide-13C, d3 is the 13C- and deuterium labeled Ethosuximide (HY-B1378). Ethosuximide, a widely prescribed anti-epileptic agent, improves the phenotypes of multiple neurodegenerative disease models and blocks the low voltage activated T-type calcium channel. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ethosuximide-d5 | Ethosuximide-d5 is deuterium labeled Ethosuximide. Ethosuximide, a widely prescribed anti-epileptic agent, improves the phenotypes of multiple neurodegenerative disease models and blocks the low voltage activated T-type calcium channel. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
RS-86 | RS-86 is a potent, central acting, and selective muscarinic acetylcholine receptor agonist. RS-86 exhibits typical cholinergic excitatory effects, such as inducing smooth muscle contraction, ganglion depolarization, central hypothermia, etc. RS-86 can be used for research on Alzheimer's disease. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Succinimide | 99.92% | Succinimide is a modifying agent. Binding of Succinimide to the 5-HT7 receptor induces clathrin-mediated endocytosis. Succinimide-modified liposomes exhibit high cellular uptake. Succinimide can be used in the study of glioblastoma. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Succinimide-15N | 99.0% | Succinimide-15N is the 15N-labeled Succinimide (HY-41877). Succinimide is a modifying agent. Binding of Succinimide to the 5-HT7 receptor induces clathrin-mediated endocytosis. Succinimide-modified liposomes exhibit high cellular uptake. Succinimide can be used in the study of glioblastoma. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Bemegride | 99.96% | Bemegride (3-Ethyl-3-methylglutarimide) is a central nervous system stimulant and antidote for barbiturate poisoning. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
8-Azaspiro[4.5]decane-7,9-dione (Standard) | ≥98% | 8-Azaspiro[4.5]decane-7,9-dione (Standard) is the analytical standard of 8-Azaspiro[4.5]decane-7,9-dione. This product is intended for research and analytical applications. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Piperidione | Piperidione is a cough agent. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(R)-3-Aminopyrrolidine-2,5-dione | (R)-3-Aminopyrrolidine-2,5-dione is a potential anticonvulsant agent and its derivatives have comparable in vivo efficacy. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(S)-3-Aminopyrrolidine-2,5-dione | (S)-3-Aminopyrrolidine-2,5-dione is a potential anticonvulsant agent and its derivatives have comparable in vivo potency. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
